Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells-Reference-Cited by-同舟云学术

Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells

Published:2011-09-15 Issue:4 Volume:30 Page:634-642
ISSN:0736-0266
Container-title:Journal of Orthopaedic Research
language:en
Short-container-title:J. Orthop. Res.

Author:

Chong Pan-Pan,Selvaratnam Lakshmi,Abbas Azlina A.,Kamarul Tunku

Publisher

Wiley

Subject

Orthopedics and Sports Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jor.21556/fullpdf

Reference29 articles.

1. Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition;Homicz;Otolaryngol Head Neck Surg,2002

2. Mesenchymal stem cells in cartilage repair: state of the art and methods to monitor cell growth, differentiation and cartilage regeneration;Galle;Curr Med Chem,2010

3. Mesenchymal stem cells: isolation and therapeutics;Alhadlaq;Stem Cell Dev,2004

4. Directing stem cell differentiation into the chondrogenic lineage in vitro;Heng;Stem Cells,2004

5. Pluripotency of mesenchymal stem cells derived from adult marrow;Jiang;Nature,2002

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral blood stem cells;OrthoBiologics;2025

2. Calcium Phosphates: A Key to Next‐Generation In Vitro Bone Modeling;Advanced Healthcare Materials;2024-08-23

3. Evaluation of in vitro osteoblast and osteoclast differentiation from stem cell: a systematic review of morphological assays and staining techniques;PeerJ;2024-07-25

4. Identifying transcriptomic profiles of iron–quercetin complex treated peripheral blood mononuclear cells from healthy volunteers and diabetic patients;Scientific Reports;2024-04-24

5. Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease;Inflammopharmacology;2024-04-14